GlaxoSmithKline International Achievement Award 2004
Nominations are now sought for the GlaxoSmithKline International Achievement
Award. The award will be made to an individual, from anywhere in the world,
who has demonstrated through published work, over the past three years, a substantial
advancement in the application of scientific knowledge within the pharmaceutical
sciences. Alternatively, the award may be made to a team of up to six researchers.
The award is open to researchers in academia, industry, public service or any
other scientific establishment or to researchers from these areas working collaboratively.
Although it is probable that applicants will be successful scientists in their
field, perhaps in mid-career, there is no age limit for applicants and each case
will be judged on scientific quality and its actual or future applicability to
industrial practice.
The award will comprise a commemorative presentation, a cheque for £1,000
and expenses for the successful applicant (or leader of the successful team)
to attend the British Pharmaceutical Conference in September 2004 to give a lecture
on the subject.
Nominations are requested either directly from the scientists concerned, or from
any other individual or organisation within the pharmaceutical sciences on behalf
of an individual or group. The nomination should consist of a curriculum vitae
of the principal researcher (who would give the lecture if successful), a summary
CV (one page) for each other team member, together with a summary (no more than
1,000 words) of their published work over the past three years and its importance
to the pharmaceutical industry.
Previous winners are Professor Hans Lennernäs (Uppsala University), Professor
Patrick Couvreur (Université Paris-Sud), Professor William Charman (Monash
University, Victoria), Professor Bob Langer (Massachusetts Institute of Technology),
Professor Sandy Florence (University of London), Dr Peter Byron (Virginia Commonwealth
University) and Professor Martyn Davies and colleagues (team award, University
of Nottingham).
Nominations should be sent to Dr J. A. Clements at the Royal Pharmaceutical Society’s
headquarters (Room 304) before 30 November 2003. The nominations will be judged
by a review panel of senior staff from GlaxoSmithKline.
|
